These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 15573431)

  • 1. Protecting vulnerable research subjects: practical realities of institutional review board review and approval.
    Wichman A
    J Health Care Law Policy; 1998; 1(1):88-104. PubMed ID: 15573431
    [No Abstract]   [Full Text] [Related]  

  • 2. Institutional review boards (IRBs) failed to use steps to protect vulnerable research subjects.
    Maloney DM
    Hum Res Rep; 2003 Jun; 18(6):6-7. PubMed ID: 15119342
    [No Abstract]   [Full Text] [Related]  

  • 3. Institutional review boards. A net too thin.
    Palca J
    Hastings Cent Rep; 1996; 26(3):4. PubMed ID: 8736666
    [No Abstract]   [Full Text] [Related]  

  • 4. Half-full or half-empty? Evaluating IRB performance.
    Mishkin B; Ariand N
    Prof Ethics Rep; 1998; 11(3):4-7. PubMed ID: 11657925
    [No Abstract]   [Full Text] [Related]  

  • 5. Federal investigation concludes that institutional review boards are in trouble.
    Maloney DM
    Hum Res Rep; 1998 Aug; 13(8):1-2. PubMed ID: 11657190
    [No Abstract]   [Full Text] [Related]  

  • 6. Protecting human research subjects: ten common problems.
    Puglisi T
    Health Law News; 2000 Jun; 13(3):8, 15. PubMed ID: 12542046
    [No Abstract]   [Full Text] [Related]  

  • 7. Recommendations for federal "super agency" would affect institutional review boards.
    Maloney DM
    Hum Res Rep; 2001 Feb; 16(2):1-3. PubMed ID: 12530378
    [No Abstract]   [Full Text] [Related]  

  • 8. Medical research oversight from the corporate governance perspective: comparing institutional review boards and corporate boards.
    Saver RS
    William Mary Law Rev; 2004 Nov; 46(2):619-730. PubMed ID: 17167924
    [No Abstract]   [Full Text] [Related]  

  • 9. Protecting research subjects--what must be done.
    Shalala D
    N Engl J Med; 2000 Sep; 343(11):808-10. PubMed ID: 10984573
    [No Abstract]   [Full Text] [Related]  

  • 10. United States regulatory requirements for research involving human subjects.
    J Biolaw Bus; 1998; 1(2):39-53. PubMed ID: 12739542
    [No Abstract]   [Full Text] [Related]  

  • 11. Research involving children: regulations, review boards and reform.
    Gandhi R
    J Health Care Law Policy; 2005; 8(2):264-330. PubMed ID: 16471026
    [No Abstract]   [Full Text] [Related]  

  • 12. Human subject protections in the United States: perspectives from the Office for Protection from Research Risks.
    Russell-Einhorn M; Ellis GB
    J Biolaw Bus; 1998; 1(2):36-8. PubMed ID: 12739540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Institutional review boards, research on children, and informed consent of parents: walking the tightrope between encouraging vital experimentation and protecting subjects' rights.
    Katerberg RJ
    J Coll Univ Law; 1998; 24(3):545-79. PubMed ID: 16331880
    [No Abstract]   [Full Text] [Related]  

  • 14. Institutional review boards and the privacy of human research subjects.
    Maloney DM
    Hum Res Rep; 2002 Aug; 17(8):1-2. PubMed ID: 12731492
    [No Abstract]   [Full Text] [Related]  

  • 15. Research compliance changes will affect rules on protection of human subjects.
    Maloney DM
    Hum Res Rep; 1999 May; 14(5):1-2. PubMed ID: 11657776
    [No Abstract]   [Full Text] [Related]  

  • 16. Institutional review boards and institutions not doing enough to protect human subjects.
    Maloney DM
    Hum Res Rep; 2000 Jun; 15(6):1-3. PubMed ID: 12199292
    [No Abstract]   [Full Text] [Related]  

  • 17. Institutional review boards not paying enough attention to active research projects.
    Maloney DM
    Hum Res Rep; 1998 Nov; 13(11):1-2. PubMed ID: 11657741
    [No Abstract]   [Full Text] [Related]  

  • 18. Faculty guide to the institutional review board process.
    Kaktins NM
    Nurse Educ; 2009; 34(6):244-8. PubMed ID: 19901736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vulnerable persons in biomedical research: 50 years after the Nuremberg Code.
    Dickens BM
    J Int Bioethique; 1999; 10(1-2):13-23. PubMed ID: 11806429
    [No Abstract]   [Full Text] [Related]  

  • 20. A pilot project: bioethics consultants as non-voting members of IRBs at the National Institutes of Health.
    DeRenzo EG; Wichman A
    IRB; 1990; 12(6):6-8. PubMed ID: 11651266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.